Related Experiment Videos
[Cardiovascular complications of collagen diseases]
Insights
Cardiovascular complications in collagen diseases are increasingly diagnosed early. Long-term corticosteroid use also raises the risk of atherosclerotic cardiovascular issues in these patients.
Area of Science:
- Clinical epidemiology
- Cardiovascular medicine
- Rheumatology
Context:
- Collagen diseases, including systemic lupus erythematosus, systemic sclerosis, and others, present significant cardiovascular risks.
- Cardiovascular complications are a major concern in patients with these autoimmune conditions.
Purpose:
- To review recent advancements in the diagnosis and clinical epidemiology of cardiovascular complications in collagen diseases.
- To highlight emerging trends in cardiovascular involvement and its management.
Summary:
- Major cardiac issues include pericarditis, myocardial disease, conduction abnormalities, coronary artery disease, and valvular disease.
- Vascular complications involve necrotizing vasculitis and Raynaud's phenomenon.
- Improved diagnostic methods enhance early detection, while corticosteroid therapy contributes to atherosclerotic complications.
Impact:
- Increased early diagnosis of cardiovascular complications in collagen disease patients.
- Growing awareness of corticosteroid-induced cardiovascular risks.
- Informs clinical practice and future research in rheumatology and cardiology.
Abstract:
Recent progress in the field of clinical epidemiology and diagnosis of major cardiovascular complications of collagen diseases were reviewed including systemic lupus erythematosus, systemic sclerosis, polymyositis.dermatomyositis, polyarteritis and mixed connective tissue disease. Major cardiac complications comprise pericarditis, myocardial disease, cardiac conduction system disease, coronary artery disease and valvular disease. Vascular complications comprise necrotizing vasculitis as a major organic involvement and Raynaud's phenomenon as a major functional involvement. Due to the recent development of sensitive methods of evaluating cardiovascular abnormalities, clinical diagnosing rate of cardiovascular complications in the early stage has been considerably increasing in patients with collagen diseases. On the other hand, number of patients with atherosclerotic cardiovascular complications due to long-term corticosteroid therapy has been also gradually increasing.